Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • standonn
    Member
    • Nov 2014
    • 14

    FastQC: 2 peak per sequence GC content

    Dear all,

    I have some genomic pair-end data from a nematode. I ran FASTQC to have an overview of the data.

    I was surprised to see a "Per sequence GC content" graph with 2 peaks (see image attached).
    I ran trimmomatic but the graph of per sequence GC content remained the same.
    Do you know why I get this profile?

    Best,
    Sophie
    Attached Files
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    It *may* be indicative of contamination from an unrelated species/source. Have you tried to analyze the data? Is this a simple WGS experiment?

    Comment

    • bastianwur
      Member
      • Feb 2014
      • 98

      #3
      What should be the normal GC content? 41? Is there anything within the genome, which could have the other GC content?

      I had once also 2 peaks in some samples.
      Was a low GC bacterium (30%). The second peak (50%) turned out to be totally from the rRNA operons within this bacterium. Our guess was that the GC bias of the adapter ligation kicked somehow in, and ruined the dataset. The supplier doesn't know what happened.
      I'm not sure if that could be the case here, because I don't know if you have biological differences within the DNA in your sample, but is probably worth checking.

      Comment

      • standonn
        Member
        • Nov 2014
        • 14

        #4
        Hello GenoMax and bastianwur,

        Thanks a lot for your answers.

        We don´t know what the GC content is for this species. We do think it is around 35-40% as in other worms.

        After talking to the people in my lab, the second peak around 70% could very much be due to a bacterium present in the gut of the worm.

        Otherwise, the strain used is inbred but I believe still presents biological differences. I wouldn´t say that would explain the 2nd peak though.

        Do you think it is still possible to do a genome assembly on this data?

        Anyhow, thanks for your answers,
        Sophie

        Comment

        • bastianwur
          Member
          • Feb 2014
          • 98

          #5
          We're normally assembling here meta-genomes and -transcriptomes, and haven't encountered many problems with the different species.
          One of my colleagues has a paper in submission, where they investigated that and got very little false assemblies.
          -> assembling 2 totally different organisms from this dataset shouldn't be a problem.
          You might have to do some QA though, to ensure that everything gets corretly assigned/separated.

          Comment

          • HESmith
            Senior Member
            • Oct 2009
            • 512

            #6
            Hi Sophie,

            We observed a similar bimodal distribution from C. elegans samples contaminated with Streptomyces (and the relative height of the high-GC peak varied with the degree of contamination). You could BLAST a sampling of the GC-rich reads and see if they match any known species.

            Comment

            • GenoMax
              Senior Member
              • Feb 2008
              • 7142

              #7
              If you know what that bacterium (present in the gut) is (and if a genome is available for that species or a close relative) you could try to separate your reads into two pools before trying assembly.

              You can do that easily with BBSplit.

              Comment

              • standonn
                Member
                • Nov 2014
                • 14

                #8
                Dear all,

                Sorry for the late reply.
                Thanks a lot for your answers! They were much appreciated.

                Unfortunately, I don´t know the gut bacterium of this nematode. But I´ll try doing what HESmith suggested and see if its sequenced I´ll do what GenoMax suggested.

                To Genomax: thanks for telling me about BBSplit! I didn´t know about that tool.

                To Bastianwur: Your message made me very happy! It is very good to know that there shouldn´t be problems assembling this peculiar data. Good luck for the publishing!

                Cheers,
                Sophie

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                  by SEQadmin2


                  Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                  The systematic characterization of the human proteome has
                  ...
                  07-20-2026, 11:48 AM
                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  07-09-2026, 11:10 AM
                • SEQadmin2
                  Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                  by SEQadmin2



                  Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                  There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                  07-08-2026, 05:17 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, Today, 12:17 PM
                0 responses
                10 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, Yesterday, 11:41 AM
                0 responses
                11 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-20-2026, 11:10 AM
                0 responses
                23 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-13-2026, 10:26 AM
                0 responses
                37 views
                0 reactions
                Last Post SEQadmin2  
                Working...